These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 8669042
1. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region]. Dunst J. Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042 [No Abstract] [Full Text] [Related]
3. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y. Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889 [Abstract] [Full Text] [Related]
8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ. Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857 [Abstract] [Full Text] [Related]
9. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children]. Konoplia NE, Strongin IuS, Talabaev MV, Aleĭnikova OV. Vopr Onkol; 2008 Mar; 54(2):157-63. PubMed ID: 18522163 [Abstract] [Full Text] [Related]
10. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F. Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801 [Abstract] [Full Text] [Related]
11. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study. Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):204-13. PubMed ID: 15337557 [Abstract] [Full Text] [Related]
12. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors. Spreafico F, Gandola L, Marchianò A, Simonetti F, Poggi G, Adduci A, Clerici CA, Luksch R, Biassoni V, Meazza C, Catania S, Terenziani M, Musumeci R, Fossati-Bellani F, Massimino M. Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1011-9. PubMed ID: 17904307 [Abstract] [Full Text] [Related]
14. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL. Cancer; 2009 Jul 01; 115(13):2956-63. PubMed ID: 19402050 [Abstract] [Full Text] [Related]
15. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Duffner PK, Horowitz ME, Krischer JP, Burger PC, Cohen ME, Sanford RA, Friedman HS, Kun LE. Neuro Oncol; 1999 Apr 01; 1(2):152-61. PubMed ID: 11554387 [No Abstract] [Full Text] [Related]
16. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S. Pediatr Blood Cancer; 2008 Feb 01; 50(2):312-8. PubMed ID: 17668858 [Abstract] [Full Text] [Related]
18. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study. Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Zeltzer PM. Pediatr Blood Cancer; 2005 Oct 15; 45(5):676-82. PubMed ID: 16007595 [Abstract] [Full Text] [Related]
19. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group. J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523 [Abstract] [Full Text] [Related]
20. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation? Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H. Pediatr Blood Cancer; 2009 Jul 20; 52(7):796-803. PubMed ID: 19202566 [Abstract] [Full Text] [Related] Page: [Next] [New Search]